Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will continue. 

Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200

The recent agreement with Cipla adds to the list of partnerships Formosa has formed for APP13007.

Formosa Pharmaceuticals enters into licensing agreement with Cipla for commercialization of APP13007 across 11 countries

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed them for 18 months.

Stem cell-based CALEC therapy achieves 90% corneal surface restoration in clinical trial

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other atrophic macular pathologies to be incorrectly diagnosed, which can impact treatment. 

 Investigators highlight the risk of misdiagnosing geographic atrophy

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Proactive Glaucoma Management: Tailoring Treatment for Enhanced Patient Outcomes

Video Series

Approaches to Selecting MIGS for Individualizing Glaucoma Management 

Videos

Albert S. Khouri, MD, describes two patient cases with different stages of glaucoma and discusses interventional treatment options, including selective laser trabeculoplasty and various MIGS devices.

Dr Albert S Khouri, MD presents a case of a glaucoma patient and discusses his approach to medical management of glaucoma.  

Glaucoma Management in a Newly Diagnosed Patient 

Dr Khouri discusses selective laser trabeculoplasty (SLT) as a first-line treatment for glaucoma and identifies patients who would be good candidates for this procedure. 

SLT as First-line Treatment for Glaucoma 

Dr Khouri presents a case of a glaucoma patient who underwent multiple SLT procedures and would be a good candidate for MIGS. 

Glaucoma Management in a Patient with Prior SLT 

Dr. Khouri discusses the MIGS procedures he performs in his practice and his approach to selecting the most appropriate procedure for each patient. 

Approaches to Selecting MIGS for Individualizing Glaucoma Management

EP: 1.Glaucoma Management in a Newly Diagnosed Patient

EP: 2.SLT as First-line Treatment for Glaucoma

EP: 3.Glaucoma Management in a Patient with Prior SLT

EP: 4.Approaches to Selecting MIGS for Individualizing Glaucoma Management